NovaBridge Biosciences growth metrics data for the quarter ended Dec 2025. These growth metrics cover 8 quarters of results from Dec 2019 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Dec2019 | Sep2023 | Dec2023 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|
| Growth Ratios | ||||||||
| EBITDA Margin Growth (3y) | -78.93M | |||||||
| EBITDA Margin (QoQ) | 0.42M | -78.59M | ||||||
| EBIT Margin Growth (3y) | -78.93M | |||||||
| EBIT Margin (QoQ) | 0.42M | -78.59M | ||||||
| EBT Margin Growth (3y) | -73.83M | |||||||
| EBT Margin (QoQ) | 1.47M | -73.56M | ||||||
| Interest Coverage Ratio (QoQ)Interest Cover (QoQ) | 9.98% | |||||||
| Net Margin Growth (3y) | -133.23M | |||||||
| Net Margin (QoQ) | 2.81M | -132.16M | ||||||
| Operating Margin Growth (3y) | -78.93M | |||||||
| Operating Margin (QoQ) | 0.42M | -78.59M | ||||||
| Return on Assets [ROA] Growth (1y)ROA Growth (1y) | 0.01M | 0.00M | ||||||
| Return on Assets [ROA] Growth (5y)ROA Growth (5y) | -0.00M | |||||||
| Return on Assets [ROA] (QoQ)ROA (QoQ) | 0.01M | 366.00 | 105.00 | 0.00M | -0.00M | |||
| Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) | 0.00M | -0.00M | ||||||
| Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y) | -0.00M | |||||||
| Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) | 948.00 | 27.00 | 470.00 | 366.00 | -0.00M | |||
| Return on Sales [ROS] Growth (3y)ROS Growth (3y) | -78.93M | |||||||
| Return on Sales [ROS] (QoQ)ROS (QoQ) | 0.42M | -78.59M |